222. 一次性ネフローゼ症候群 ［臨床試験数：234，薬物数：241（DrugBank：78），標的遺伝子数：59，標的パスウェイ数：185］
Searched query = "Primary nephrotic syndrome", "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||ChiCTR-IPR-17011702||2017-07-01||2017-06-19||Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid||Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid||membranous nephropathy||mizoribine group:treated with mizoribine and steroid;cyclophosphamide group:treated with cyclophosphamide and steroid;||Tianjin First Central Hospital||NULL||Pending||18||65||Both||mizoribine group:50;cyclophosphamide group:50;||China|
|2||JPRN-UMIN000008919||2012/09/15||14/09/2012||The prospective multi-center study on the efficacy and safety of mizoribine for the treatment of aged nephrotic patients with primary membranous nephropathy.||The patients with nephrotic syndrome due to primary membranous nephropathy.||Treatment with a combination of mizoribine plus steroid therapy|
Treatment with steroid monotherapy
|The study group of treatment for aged patients with nephrotic syndrome.||NULL||Complete: follow-up complete||65years-old||Not applicable||Male and Female||200||Not applicable||Japan|
|3||JPRN-C000000158||2006/03/01||01/04/2006||Mizoribin for primary nephrotic syndrome in children(JSRDC09)||Steroid-sensitive nephrotic syndrome||mizoribine+prednisolone||Japanese Study Group of Renal Disease in Children(JSRDC)||NULL||Complete: follow-up complete||1years-old||10years-old||Male and Female||50||Not selected||Japan|
|4||JPRN-C000000368||2004/04/01||27/03/2006||Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome||membranous nephropathy with primary steroid resistant nephrotic syndrome||mizoribine once a day per os administration (150mg) after breakfast for 2years.|
mizoribine 3 times a day per os administration (50mg each) after meals for 2years.
|Project team for treatment of refractory nephrotic syndrome||The Progressive Renal Disease Research Projects in the Ministry of Health, Labor and Welfare, Japan||Complete: follow-up complete||16years-old||75years-old||Male and Female||100||Not selected||Japan|
|5||JPRN-C000000379||2001/04/01||01/04/2006||Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)||Steroid-sensitive nephrotic syndrome||prednisolone |
|Japanese Study Group of Renal Disease in Children(JSRDC)||NULL||Complete: follow-up complete||1years-old||10years-old||Male and Female||50||Not selected||Japan|